Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/14242| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Irena Kafedziska | en_US |
| dc.contributor.author | Mishevska Perchinkova, Snezhana | en_US |
| dc.contributor.author | Antova, Dubravka | en_US |
| dc.contributor.author | Kotevska Nikolova, Mimoza | en_US |
| dc.contributor.author | Stojanovska, Anzhelika | en_US |
| dc.contributor.author | Guchev, Filip | en_US |
| dc.date.accessioned | 2021-07-29T11:25:49Z | - |
| dc.date.available | 2021-07-29T11:25:49Z | - |
| dc.date.issued | 2020 | - |
| dc.identifier.uri | http://hdl.handle.net/20.500.12188/14242 | - |
| dc.language.iso | en | en_US |
| dc.publisher | Science Publishing Group | en_US |
| dc.relation.ispartof | American Journal of Internal Medicine | en_US |
| dc.title | Multicenter, Open-Label, Long-term Extension to Describe the Safety of Tocilizumab in Patients with Early, Moderate to Severe Rheumatoid Arthritis | en_US |
| dc.type | Article | en_US |
| dc.identifier.doi | 10.11648/j.ajim.20200803.16 | - |
| dc.identifier.url | http://article.sciencepublishinggroup.com/pdf/10.11648.j.ajim.20200803.16.pdf | - |
| dc.identifier.volume | 8 | - |
| dc.identifier.issue | 3 | - |
| dc.identifier.fpage | 125 | - |
| item.grantfulltext | none | - |
| item.fulltext | No Fulltext | - |
| crisitem.author.dept | Faculty of Medicine | - |
| crisitem.author.dept | Faculty of Medicine | - |
| Appears in Collections: | Faculty of Medicine: Journal Articles | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.